Scroll
Biorelate

Biorelate

Medical data curation

Sector
Application software
YFM investment
£3.9m
Investment date(s)
2022
Deal type
Growth Capital
Location
Manchester

The Business

BioRelate develops AI-powered technology that helps pharmaceutical and life sciences organisations make better use of complex biomedical data. Its platform uses natural language processing and machine learning to transform unstructured scientific information into clear, actionable insights.

By bringing together relevant research and data at scale, BioRelate helps drug discovery teams uncover connections, make informed decisions and accelerate the development of new treatments.

“Drug discovery is so exciting right now, as there are just so many incredible companies working on remarkable new therapeutics. Our mission at Biorelate is to capture this untapped data and help them make sense of it. With this improved understanding we are empowering these companies to make better decisions and speed up the drug discovery process.”

Dan Jamieson, Founder & CEO